<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>accumulative on KonFound-it!</title>
    <link>https://www.konfound-it.org/tags/accumulative/</link>
    <description>Recent content in accumulative on KonFound-it!</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    <copyright>&amp;copy; 2020. All rights reserved.</copyright>
    <lastBuildDate>Wed, 13 May 2020 00:00:00 +0000</lastBuildDate>
    <atom:link href="https://www.konfound-it.org/tags/accumulative/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>What do we do as more studies come out?</title>
      <link>https://www.konfound-it.org/2020/05/13/robustness-for-accumulating-studies-antihypertensive-treatments/</link>
      <pubDate>Wed, 13 May 2020 00:00:00 +0000</pubDate>
      <guid>https://www.konfound-it.org/2020/05/13/robustness-for-accumulating-studies-antihypertensive-treatments/</guid>
      <description>Online dashboards, such as the COVID-19 clinical trials registry, provide near real-time tracking and categorization of findings accumulating across emerging research. As such one can update the robustness of the cumulative findings for a given COVID-19 treatment. We illustrate using a historical non-COVID example: the study-by-study accumulation of \(16\) estimated effects presented in a meta-analysis of randomized trials examining the impact of hypertension treatments on the probability of suffering a stroke (data from Collins et al.</description>
    </item>
  </channel>
</rss>
